968 related articles for article (PubMed ID: 22110105)
1. Urinary sodium and potassium excretion and risk of cardiovascular events.
O'Donnell MJ; Yusuf S; Mente A; Gao P; Mann JF; Teo K; McQueen M; Sleight P; Sharma AM; Dans A; Probstfield J; Schmieder RE
JAMA; 2011 Nov; 306(20):2229-38. PubMed ID: 22110105
[TBL] [Abstract][Full Text] [Related]
2. Urinary sodium and potassium excretion, mortality, and cardiovascular events.
O'Donnell M; Mente A; Rangarajan S; McQueen MJ; Wang X; Liu L; Yan H; Lee SF; Mony P; Devanath A; Rosengren A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Yusoff K; Iqbal R; Ilow R; Mohammadifard N; Gulec S; Yusufali AH; Kruger L; Yusuf R; Chifamba J; Kabali C; Dagenais G; Lear SA; Teo K; Yusuf S;
N Engl J Med; 2014 Aug; 371(7):612-23. PubMed ID: 25119607
[TBL] [Abstract][Full Text] [Related]
3. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S;
BMJ; 2019 Mar; 364():l772. PubMed ID: 30867146
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and risk of cardiovascular events and mortality.
O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
[TBL] [Abstract][Full Text] [Related]
5. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.
Mills KT; Chen J; Yang W; Appel LJ; Kusek JW; Alper A; Delafontaine P; Keane MG; Mohler E; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Steigerwalt S; Townsend R; He J;
JAMA; 2016 May 24-31; 315(20):2200-10. PubMed ID: 27218629
[TBL] [Abstract][Full Text] [Related]
6. The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease.
Groenland EH; Vendeville JP; Bots ML; de Borst GJ; Nathoe HM; Ruigrok YM; Blankestijn PJ; Visseren FLJ; Spiering W;
PLoS One; 2022; 17(3):e0265429. PubMed ID: 35298524
[TBL] [Abstract][Full Text] [Related]
7. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
8. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.
Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; Butler J; Zannad F; Rossignol P
Clin Res Cardiol; 2016 Jun; 105(6):489-507. PubMed ID: 26615605
[TBL] [Abstract][Full Text] [Related]
9. Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin Americans.
Lamelas PM; Mente A; Diaz R; Orlandini A; Avezum A; Oliveira G; Lanas F; Seron P; Lopez-Jaramillo P; Camacho-Lopez P; O Donnell MJ; Rangarajan S; Teo K; Yusuf S
Am J Hypertens; 2016 Jul; 29(7):796-805. PubMed ID: 26683344
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.
Rosenstock J; Marx N; Neubacher D; Seck T; Patel S; Woerle HJ; Johansen OE
Cardiovasc Diabetol; 2015 May; 14():57. PubMed ID: 25990013
[TBL] [Abstract][Full Text] [Related]
12. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
13. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.
Mente A; O'Donnell M; Rangarajan S; McQueen M; Dagenais G; Wielgosz A; Lear S; Ah STL; Wei L; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Mony P; Szuba A; Iqbal R; Yusuf R; Mohammadifard N; Khatib R; Yusoff K; Ismail N; Gulec S; Rosengren A; Yusufali A; Kruger L; Tsolekile LP; Chifamba J; Dans A; Alhabib KF; Yeates K; Teo K; Yusuf S
Lancet; 2018 Aug; 392(10146):496-506. PubMed ID: 30129465
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with heart failure hospitalization in patients with high sodium excretion: subanalysis of the ESPRIT, evaluation of sodium intake for the prediction of cardiovascular events in Japanese high-risk patients, cohort study.
Sadanaga T; Hirota S; Mitamura H
Heart Vessels; 2021 Jan; 36(1):85-91. PubMed ID: 32720095
[TBL] [Abstract][Full Text] [Related]
15. Association between 24h Urinary Sodium and Potassium Excretion and Estimated Glomerular Filtration Rate (eGFR) Decline or Death in Patients with Diabetes Mellitus and eGFR More than 30 ml/min/1.73m2.
Nagata T; Sobajima H; Ohashi N; Hirakawa A; Katsuno T; Yasuda Y; Matsuo S; Tsuboi N; Maruyama S
PLoS One; 2016; 11(5):e0152306. PubMed ID: 27136292
[TBL] [Abstract][Full Text] [Related]
16. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG
Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911
[TBL] [Abstract][Full Text] [Related]
18. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
Ma Y; He FJ; Sun Q; Yuan C; Kieneker LM; Curhan GC; MacGregor GA; Bakker SJL; Campbell NRC; Wang M; Rimm EB; Manson JE; Willett WC; Hofman A; Gansevoort RT; Cook NR; Hu FB
N Engl J Med; 2022 Jan; 386(3):252-263. PubMed ID: 34767706
[TBL] [Abstract][Full Text] [Related]
19. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
20. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
